PRINCETON, N.J., Oct. 29, 2007 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that executive management will participate in the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference to be held at the New York Palace Hotel in New York City during November 5 through November 7, 2007. Dr. Geert Cauwenbergh, Chief Executive Officer of Barrier, is scheduled to present an overview of the Company’s commercial operations and development programs on Tuesday, November 6, at 10:15 a.m. EST.
